title: Preventing hepatitis B reactivation associated with immunosuppressive drug treatments for psoriasis.
authors.affiliation: Georgia Regents University Medical College of Georgia, Augusta, Georgia.
authors.forename: Iviensan F
authors.initials: IF
authors.lastname: Manalo
authors.affiliation: Indiana University School of Medicine, Indianapolis, Indiana.
authors.forename: Kathleen E
authors.initials: KE
authors.lastname: Gilbert
authors.affiliation: Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. Electronic address: jashinwu@hotmail.com.
authors.forename: Jashin J
authors.initials: JJ
authors.lastname: Wu
mesh_terms: D006515:Hepatitis B virus / Q000502:physiology*; D019694:Hepatitis B, Chronic / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D012008:Recurrence; D012698:Serologic Tests; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D007166:Immunosuppressive Agents
keywords: biologics; hepatitis B virus; immunosuppressants; immunosuppressive drug therapy; psoriasis; reactivation